Purchase Order N6809421P6055
Award Date 10/1/21
Potential Completion Date 9/5/26
Potential Value $85K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Raritan, NJ 08869, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the Defense Health Agency (DHA) to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer self-certified as a HUBZone joint venture. The award, with a ceiling value of $1,266,899.75, is for the delivery of MTS A/B/D MONO 7REV GROUP 5X20 medical diagnostic equipment and associated supplies under the Critical Analyzers, Laboratory (FSS-66-III) GSA schedule. The contract is a Firm Fixed Price Delivery Order with an ultimate completion...
- This is a federal contract award from the Medical Supply Chain (an alternate name for the Defense Agency), valued at $1,305.93, awarded to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The contract is a Delivery Order, with a fixed price and economic price adjustment pricing type, and an ultimate completion date of June 20, 2025. It does not have a set-aside designation. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture that specializes...
- This is a $1,255.63 fixed-price delivery order awarded by the Defense Health Agency (DHA) to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer and self-certified HUBZone joint venture. The contract is for the supply of "ANTI-M 1X5ML" medical products, with a period of performance through April 23, 2025. The contract does not utilize a set-aside designation, indicating open competition. Ortho-Clinical Diagnostics, Inc. is a key supplier of sophisticated...
- This is a federal contract award to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, by the Medical Supply Chain division of the Defense Department's Defense Health Agency. The $1,767.32 firm fixed-price delivery order is for the supply of 4,568,212,039 units of Anti-A,B Bioclone 15x10ml. The contract has a June 2, 2025 completion date and does not utilize a set-aside designation, indicating open competition. Ortho-Clinical Diagnostics, Inc. is a self-certified...
- This is a firm fixed-price federal contract award to Ortho-Clinical Diagnostics Inc., a for-profit medical equipment manufacturer and self-certified HUBZone joint venture, by the Defense Health Agency. The $22,000.68 contract is for medical supplies and services, including clinical chemistry analyzers, immunoassay systems, blood typing instruments, and related consumables to support medical testing and diagnostic capabilities across federal healthcare institutions. The award is not associated...
- This is a $4,418.30 fixed-price delivery order awarded to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturer, by the Defense Health Agency for blood group serum supplies. The order has a period of performance ending on November 29, 2024. Ortho-Clinical Diagnostics is a for-profit organization and self-certified HUBZone joint venture that has previously provided medical equipment, reagents, and testing services to federal agencies including the Department of Veterans Affairs and...
- This is a federal contract award to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer and self-certified HUBZone joint venture, by the Medical Supply Chain division of the Defense agency. The $5,299.18 fixed-price delivery order contract is for the supply of 4,568,054,958 units of "ANTI-DST 15X10ML" medical products, with a completion date of May 12, 2025. The contract was awarded on April 28, 2025 and does not utilize any set-aside designations,...
- This is a federal contract award to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, for the delivery of ANTI-M 1X5ML medical supplies. The $1,657.70 fixed-price contract with economic price adjustment was awarded by the Medical Supply Chain agency, which is an alternate name for the Defense agency. The contract is a delivery order with a completion date of May 19, 2025 and does not utilize any set-aside designations, indicating open competition. Ortho-Clinical...
- This is a federal contract award from the Defense Health Agency (DHA) to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The $5,739.54 firm fixed-price delivery order is for the supply of 4567948697 REAGENT ANTI-D BIOCLONE 150ML MONOCLONAL. The contract has an ultimate completion date of April 21, 2025 and was awarded on April 16, 2025. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture and the contract does not utilize any set-aside...
- This is a delivery order contract awarded by the Defense Health Agency to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturing company, for the provision of urine protein testing kits. The $3,832.90 firm fixed price contract has an ultimate completion date of October 3, 2024. Ortho-Clinical Diagnostics is a for-profit organization and self-certified HUBZone joint venture that has previously provided a range of diagnostic solutions, laboratory equipment, reagents, and testing...